[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2021, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelli  Collin M.S.", "title": "Senior Vice President of Quality", "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1711929600, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.9, "open": 9.63, "dayLow": 9.4658, "dayHigh": 9.89, "regularMarketPreviousClose": 9.9, "regularMarketOpen": 9.63, "regularMarketDayLow": 9.4658, "regularMarketDayHigh": 9.89, "beta": 2.126, "forwardPE": -5.494382, "volume": 112149, "regularMarketVolume": 112149, "averageVolume": 328938, "averageVolume10days": 288680, "averageDailyVolume10Day": 288680, "bid": 9.76, "ask": 9.84, "bidSize": 200, "askSize": 100, "marketCap": 465047776, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 11.11, "priceToSalesTrailing12Months": 280.65646, "fiftyDayAverage": 9.215, "twoHundredDayAverage": 5.174555, "currency": "USD", "enterpriseValue": 337880384, "floatShares": 30263750, "sharesOutstanding": 47550900, "sharesShort": 1797371, "sharesShortPriorMonth": 1654561, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0378, "heldPercentInsiders": 0.13238, "heldPercentInstitutions": 0.59900004, "shortRatio": 6.09, "shortPercentOfFloat": 0.056900002, "impliedSharesOutstanding": 47550900, "bookValue": 3.062, "priceToBook": 3.1939907, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -87298000, "trailingEps": -2.05, "forwardEps": -1.78, "enterpriseToRevenue": 203.911, "enterpriseToEbitda": -3.856, "52WeekChange": 2.26, "SandP52WeekChange": 0.21080327, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.78, "targetHighPrice": 28.0, "targetLowPrice": 11.0, "targetMeanPrice": 15.75, "targetMedianPrice": 12.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 130625000, "totalCashPerShare": 2.751, "ebitda": -87615000, "totalDebt": 4202000, "quickRatio": 11.405, "currentRatio": 12.505, "totalRevenue": 1657000, "debtToEquity": 2.904, "revenuePerShare": 0.039, "returnOnAssets": -0.31399, "returnOnEquity": -0.54415, "freeCashflow": -49609624, "operatingCashflow": -81228000, "revenueGrowth": 0.831, "operatingMargins": -26.121851, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-26"}]